Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism
2008

Fibrinogen's Effect on Heart Cell Function

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Boyd John H, Chau Edmond H, Tokunanga Chiho, Bateman Ryon M, Haljan Greg, Davani Ehsan Y, Wang Yinjin, Walley Keith R

Primary Institution: University of British Columbia

Hypothesis

Does fibrinogen and its degradation products alter cardiomyocyte contractile function through interaction with ICAM-1?

Conclusion

The amino acid sequence 117–133 of the fibrinogen gamma chain decreases cardiomyocyte contractility by binding to ICAM-1.

Supporting Evidence

  • Endotoxin administration decreased cardiac contractility and increased ICAM-1 and fibrinogen levels.
  • Fibrinogen specifically binds to ICAM-1 on cardiomyocytes.
  • Blocking ICAM-1 prevents fibrinogen from decreasing heart cell contractility.

Takeaway

Fibrinogen can make heart cells weaker by sticking to a specific part on their surface called ICAM-1.

Methodology

Rats were injected with endotoxin to model inflammation, and isolated cardiomyocytes were treated with TNF-alpha to study contractility changes.

Limitations

The study was conducted on rats, which may not fully represent human physiology.

Participant Demographics

Male Sprague-Dawley rats, 350 to 450 g in weight.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/cc6213

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication